In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation. (2014)
Attributed to:
Developing targeted therapeutics for keratinizing skin disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2014.10.022
PubMed Identifier: 25449884
Publication URI: http://europepmc.org/abstract/MED/25449884
Type: Journal Article/Review
Volume: 196
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659